Egetis Therapeutics AB (EGTX.ST) Q4 2024 Earnings

Nov 8Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.32
-0.29
-0.27
-0.24

Details

Expected EPS
-0.3180198
Actual EPS
-0.30045136945
Surprise EPS
0.02
Surprise Percent
+5.52%

Description

⁨Egetis Therapeutics AB⁩ (⁦EGTX.ST⁩) has reported earnings of ⁦-0.30045136945⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts